Q2 2023 revenues of $681.9 million, up 15.9% year-over-year (yoy); organic revenue up 13.5% yoy Q2 2023 GAAP EPS $0.39; non-GAAP EPS $0.50, up 11.1% yoy Bruker increases FY 2023 revenue guidance to $2.85-$2.90 billion; implies revenue growth of 12.5%-14.5%, and organic revenue growth at 9.5%-11.5% BILLERICA, Mass.–(BUSINESS WIRE)– Bruker Corporation (Nasdaq: BRKR) today announced... Read more
WALTHAM, Mass.–(BUSINESS WIRE)– Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today reported its financial results for the second quarter ended July 1, 2023. Second Quarter 2023 Highlights Second quarter revenue was $10.69 billion, 3% lower versus the same quarter last year. Core organic revenue growth was 2%. Second quarter GAAP... Read more
WASHINGTON, July 25, 2023 /PRNewswire/ — Danaher Corporation (NYSE: DHR) (the “Company”) today announced results for the second quarter 2023. Net earnings refer to net earnings attributable to common shareholders. For the quarter ended June 30, 2023 net earnings were $1.1 billion, or $1.49 per diluted common share and non-GAAP adjusted diluted net earnings per common... Read more
GHz-Class NMR, Structural Biology assisted by Artificial Intelligence, a New Scientific Software Division and Innovative Helium Solutions at EUROMAR 2023 GLASGOW, Scotland–(BUSINESS WIRE)– At the EUROMAR Conference 2023 in Scotland, Bruker showcases the latest innovations in magnetic resonance technology for life science and materials science research. Bruker’s contributions to science in the United Kingdom (UK)... Read more
Advances World-Class Clinical Research Capabilities with Leading Regulatory-Grade Registries Platform Expected to Be Immediately Accretive to Adjusted Earnings Per Share 1 WALTHAM, Mass.–(BUSINESS WIRE)– Thermo Fisher Scientific Inc. (NYSE: TMO) (“Thermo Fisher”), the world leader in serving science, today announced it has entered into a definitive agreement to acquire CorEvitas, LLC (“CorEvitas”), a leading provider... Read more
New EVOQ DART-TQ+ system for chromatography-free triple-quadrupole mass spectrometry for point-of-need (PoN) routine analysis Launch of impact™ II VIP ESI-TOF (time of flight) system for highest sensitivity New TargetScreener™ 4D software bringing the selectivity of TIMS (trapped ion mobility spectrometry) to high-confidence analyte screening and quantitation HOUSTON–(BUSINESS WIRE)– At the 71st ASMS meeting, Bruker Corporation... Read more
This article is translated from press release in Japanese for your convenience. Forward-Looking Statements Statements in this news release, other than those based on historical fact, concerning the current plans, prospects, strategies and expectations of the Company and its Group represent forecasts of future results. While such statements are based on the conclusions of management... Read more
BILLERICA, Mass.–(BUSINESS WIRE)– Bruker Corporation (Nasdaq: BRKR) today announced that on May 12, 2023, its Board of Directors approved a new share repurchase authorization for the purchase of up to $500 million of the Company’s common stock over a two-year period commencing on May 15, 2023. The share repurchase authorization permits shares to be repurchased... Read more
Q1 2023 revenues of $685.3 million, up 15.2% year-over-year (yoy); organic revenue up 17.6% yoy Q1 2023 GAAP EPS $0.52; non-GAAP EPS $0.64, up 30.6% yoy Bruker increases FY 2023 guidance for revenue to $2.83-$2.88 billion and for non-GAAP EPS to $2.55-$2.60; implies revenue growth to 12%-14%, and organic revenue growth of 9% – 11%... Read more
WALTHAM, Mass.–(BUSINESS WIRE)– Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today reported its financial results for the first quarter ended April 1, 2023. First Quarter 2023 Highlights Delivered very strong financial results during the first quarter. First quarter revenue was $10.71 billion, 9% lower versus the same quarter last year.... Read more